Management of Gout in Patients with a History of GI Bleeding

Treatment Options for Acute Gout Attacks

The American College of Physicians recommends corticosteroids as the preferred first-line treatment for acute gout attacks in patients with a history of gastrointestinal bleeding due to their effectiveness and lower risk of GI complications compared to NSAIDs 1, 2
Intra-articular corticosteroid injections are appropriate for patients with a history of GI bleeding when only one or few joints are affected 3
Low-dose colchicine is effective for acute gout management while minimizing GI side effects, with an initial dose of 1.2 mg followed by 0.6 mg one hour later 1, 4
Low-dose colchicine can cause gastrointestinal issues including diarrhea, nausea, vomiting, cramps, and pain, although it has fewer serious GI complications than NSAIDs 1, 5

The European League Against Rheumatism recommends low-dose colchicine (0.5-1 mg daily) as the preferred prophylactic agent during the first 6 months of urate-lowering therapy for patients with recurrent gout attacks (≥2 per year) 3
Low-dose corticosteroids can be considered as an alternative prophylactic option when colchicine is not tolerated or contraindicated in patients with a history of GI bleeding 3

The decision to initiate urate-lowering therapy should be based on frequency of attacks, not affected by GI bleeding history, and is recommended for patients with recurrent gout (≥2 episodes per year) or problematic gout (tophi, chronic renal disease, urolithiasis) 1, 6
Target serum urate levels should be maintained at <6 mg/dL (360 μmol/L), with a lower target of <5 mg/dL (300 μmol/L) for severe gout until resolution 7
Allopurinol is the first-line urate-lowering therapy, starting at low dose (100 mg/day) and titrating upward every 2-4 weeks to reach target urate levels 7

Regular monitoring of serum urate levels is essential to ensure therapeutic targets are being met, according to the American College of Physicians 8, 7

Dietary and lifestyle modifications should be emphasized for all gout patients, including weight loss if appropriate, limiting alcohol, avoiding sugar-sweetened drinks, and reducing intake of meat and seafood, as recommended by the European League Against Rheumatism 7, 3
Comorbidity screening should be performed systematically, including renal function assessment which may impact medication choices, according to the European League Against Rheumatism 3